• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

K2M

Stryker closes $1.4B K2M buy

November 9, 2018 By Fink Densford

Stryker (NYSE:SYK) said today that it closed its $1.4 billion acquisition of K2M (NSDQ:KTWO). Kalamazoo, Mich.-based Stryker paid $27.50 per share for each outstanding share of K2M, representing a 27% premium over K2M’s average closing price during the 90 days of trading ended August 29. With the acquisition, Leesburg, Va.-based K2M will become a wholly owned subsidiary […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: K2M, Stryker

FTC clears Stryker, K2M tie-up early

November 8, 2018 By Fink Densford

K2M (NSDQ:KTWO) said today that the U.S. FTC granted early termination to the Hart-Scott-Rodino Antitrust Improvement Act of 1976 waiting period for its pending $1.4 merger with Stryker (NYSE:SYK). The termination of the HSR Act clears yet another hurdle to the union between the two companies, which will position K2M as a wholly owned subsidiary of Kalamazoo, […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Orthopedics, Spine Tagged With: K2M, Stryker

K2M shareholders approve Stryker merger

November 7, 2018 By Fink Densford

K2M (NSDQ:KTWO) said today that its shareholders approved its $1.4 billion merger with Stryker (NYSE:SYK) during a special meeting of stockholders. The deal calls for Kalamazoo, Mich.-based Stryker to pay $27.50 per share for each outstanding share of K2M, for a 27% premium over K2M’s average closing price during the 90 days of trading ended August 29. K2M […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Orthopedics, Spine Tagged With: K2M, Stryker

K2M settles investor suits with updated financials on $1.4B Stryker merger

October 23, 2018 By Brad Perriello

K2M (NSDQ:KTWO) yesterday managed to mollify investors who sued to block its $1.4 billion merger with Stryker (NYSE:SYK) by releasing more details on its financials. Investors leveled the suits in the U.S. District Court for Delaware earlier this month seeking to block the deal. The purported class-action suits argued that K2M and its management failed to disclose financial projections made by […]

Filed Under: Featured, Mergers & Acquisitions, Orthopedics, Spine, Wall Street Beat Tagged With: K2M, Stryker

Stryker extends deadline on $1.4B K2M buy as shareholders sue

October 19, 2018 By Brad Perriello

Stryker (NYSE:SYK) yesterday filed to extend the anti-trust deadline on its $1.4 billion acquisition of K2M (NSDQ:KTWO) to give the U.S. Federal Trade Commission more time to examine the deal, as shareholders filed suit to block the merger, K2M said today. The new FTC filing pushes the anti-monopoly waiting period out to Nov. 16, the Leesburg, Va.-based spinal […]

Filed Under: Featured, Mergers & Acquisitions, Orthopedics, Spine, Wall Street Beat Tagged With: Anti-Trust, Federal Trade Commission (FTC), K2M, Stryker

How K2M tackled UDI and what comes next with help from Reed Tech

September 26, 2018 By Sponsored Content

Mark Zellers, Quality Assurance Specialist at K2M, is responsible for ensuring his company’s data is accurate and kept up-to-date with all sorts of outside stakeholders. One of his colleagues handles internal data management and Zellers ensures it gets to the people who need it outside K2M. A big challenge facing his team came in 2015, […]

Filed Under: Sponsored Content Tagged With: K2M, reed tech

Medtech M&A remains hot: Here’s how

September 24, 2018 By Nancy Crotti

M&A in medtech show no signs of slowing in the fourth quarter of 2018, and companies looking to buy or sell have much to consider, according to patent attorney David Dykeman, a shareholder in the Boston office of the global law firm Greenberg Traurig. The number of medtech M&A deals soared by 50% in 2017 and […]

Filed Under: Food & Drug Administration (FDA), Mergers & Acquisitions Tagged With: Analogic, augmenix, Boston Scientific, Cartiva, K2M, Stryker, wrightmedical

What you should know about today’s top trends in medtech

September 21, 2018 By Nancy Crotti

Medtech’s hottest topics in M&A, intellectual property, finance and regulation will be on the agenda at DeviceTalks Boston Oct. 8-11. Patent attorney David Dykeman from the Boston office of the global law firm Greenberg Traurig will moderate the Oct. 9 hot topics panel in which the discussion will center around: · M&A trends from the perspective of […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Health Information Technology, Mergers & Acquisitions, Regulatory/Compliance, Software / IT Tagged With: Allied Minds, altariscapitalpartners, Analogic, augmenix, Boston Scientific, Cantel Medical Corp., Cartiva, FDA, GE ventures, Greenberg Traurig, K2M, Stryker, wrightmedical

Stryker to acquire K2M for $1.4B

August 30, 2018 By Fink Densford

Stryker (NYSE:SYK) said today it inked a definitive agreement to acquire K2M (NSDQ:KTWO) for approximately $1.4 billion. In the deal, Kalamazoo, Mich.-based Stryker said it will pay $27.50 per share for each outstanding share of K2M, for a total of approximately $1.4 billion. The purchase price represents a 27% premium over K2M’s average closing price during the 90 […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Orthopedics, Spine Tagged With: K2M, Stryker

K2M posts mixed-bag Q2

August 1, 2018 By Fink Densford

K2M (NSDQ:KTWO) today posted second quarter earnings results that beat Wall Street expectations on sales, but missed on loss-per-share consensus. The Leesburg, Va.-based company posted losses of $10.8 million, or 25¢ per share, on sales of $73.6 million for the three months ended June 30, seeing losses grow 19.2% on sales growth of 12% compared with the […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: K2M

K2M readies $65 million senior note offering

June 14, 2018 By Fink Densford

K2M (NSDQ:KTWO) said this week it looks to raise $65 million through an offering of convertible senior notes due 2025. The Leesburg, Va.-based company said it also expects to grant initial note buyers an option to purchase an additional $10 million worth of the notes during a 13-day period beginning the first day it issues the notes. […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: K2M

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 5
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy